The imprinted Igf2-Igf2r axis is critical for matching placental microvasculature expansion to fetal growth.
Lam, Brian YH
Schiefer, Samira N
Yeo, Giles SH
Fowden, Abigail L
Burton, Graham J
Branco, Cristina M
Sferruzzi-Perri, Amanda N
MetadataShow full item record
Sandovici, I., Georgopoulou, A., Pérez-García, V., Hufnagel, A., López-Tello, J., Lam, B. Y., Schiefer, S. N., et al. (2022). The imprinted Igf2-Igf2r axis is critical for matching placental microvasculature expansion to fetal growth.. Dev Cell https://doi.org/10.1016/j.devcel.2021.12.005
In all eutherian mammals, growth of the fetus is dependent upon a functional placenta, but whether and how the latter adapts to putative fetal signals is currently unknown. Here, we demonstrate, through fetal, endothelial, hematopoietic, and trophoblast-specific genetic manipulations in the mouse, that endothelial and fetus-derived IGF2 is required for the continuous expansion of the feto-placental microvasculature in late pregnancy. The angiocrine effects of IGF2 on placental microvasculature expansion are mediated, in part, through IGF2R and angiopoietin-Tie2/TEK signaling. Additionally, IGF2 exerts IGF2R-ERK1/2-dependent pro-proliferative and angiogenic effects on primary feto-placental endothelial cells ex vivo. Endothelial and fetus-derived IGF2 also plays an important role in trophoblast morphogenesis, acting through Gcm1 and Synb. Thus, our study reveals a direct role for the imprinted Igf2-Igf2r axis on matching placental development to fetal growth and establishes the principle that hormone-like signals from the fetus play important roles in controlling placental microvasculature and trophoblast morphogenesis.
This work was supported by Biotechnology and Biological Sciences Research Council (grant BB/H003312/1 to M.C.), Medical Research Council (MRC_MC_UU_12012/4 to M.C.; MRC_MC_UU_12012/5 to the MRC Metabolic Diseases Unit; MR/R022690/1 to A.N.S-P.), Spanish Ministry of Science and Innovation (RYC-2019-026956 and PID2020-114459RA-I00 to V.P-G.), Wellcome Trust (Sir Henry Wellcome Postdoctoral Fellowship 220456/Z/20/Z to J.L-T.), Royal Society (Dorothy Hodgkin Research Fellowship grant DH130036 to A.N.S-P.), Centre for Trophoblast Research and the NIHR Cambridge BRC Cell Phenotyping Hub.
Biotechnology and Biological Sciences Research Council (BB/H003312/1)
Medical Research Council (MC_UU_12012/4)
Medical Research Council (MC_UU_12012/5)
Medical Research Council (MR/R022690/1)
Medical Research Council (MC_UU_12012/1)
Biotechnology and Biological Sciences Research Council (BB/S017593/1)
Embargo Lift Date
External DOI: https://doi.org/10.1016/j.devcel.2021.12.005
This record's URL: https://www.repository.cam.ac.uk/handle/1810/331286
All Rights Reserved
Licence URL: http://www.rioxx.net/licenses/all-rights-reserved